Market Tracker

08/21 3:59pm ET
1.35
Real-Time Quote
 -0.005 / -0.37%
Today’s Change
1.24
Today|||52-Week Range
3.52
-55.02%
Year-to-Date

Today’s Trading

Previous close1.35
Today’s open1.35
Day’s range1.33 - 1.38
Volume1,267,776
Average volume (3 months)2,310,608
Market cap$216.4M
Dividend yield--
Data as of 3:44pm ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)+26.42%
Earnings growth (this year)+61.79%
Earnings growth (next 5 years)-75.60%
Revenue growth (last year)-12.84%
P/E ratioNM
Price/Sales1.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TTHITransition Therapeut...-0.10-1.42%
OXFDOxford Immunotec Glo...-0.12-0.83%
VCYTVeracyte Inc-0.17-1.35%
ERBERBA Diagnostics Inc+0.07+2.41%
Data as of 3:44pm ET, 08/21/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$283.7M
Annual profit (last year)-$296.8M
Net profit margin-104.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
W. Thomas Amick
Chief Financial Officer, Treasurer &
VP
Gregory R. Cox
Corporate headquarters
Seattle, Washington

Forecasts